Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Living Donors | 15 | 2020 | 652 | 4.33 | Why? |
| Kidney Transplantation | 28 | 2021 | 5397 | 2.93 | Why? |
| Kidney Failure, Chronic | 15 | 2021 | 3222 | 1.96 | Why? |
| Tissue and Organ Procurement | 11 | 2021 | 1277 | 1.64 | Why? |
| Graft Survival | 10 | 2020 | 587 | 1.45 | Why? |
| Donor Selection | 4 | 2018 | 804 | 1.07 | Why? |
| Maintenance Chemotherapy | 1 | 2020 | 133 | 0.83 | Why? |
| Pancreas Transplantation | 2 | 2020 | 163 | 0.79 | Why? |
| Tissue and Organ Harvesting | 1 | 2020 | 146 | 0.77 | Why? |
| Analgesics, Opioid | 2 | 2019 | 1070 | 0.72 | Why? |
| Graft Rejection | 5 | 2020 | 1766 | 0.71 | Why? |
| Hospitals, Low-Volume | 1 | 2017 | 355 | 0.64 | Why? |
| Glomerular Filtration Rate | 4 | 2018 | 1262 | 0.62 | Why? |
| End Stage Liver Disease | 2 | 2019 | 418 | 0.61 | Why? |
| Nephrology | 2 | 2018 | 546 | 0.55 | Why? |
| Scleroderma, Systemic | 1 | 2020 | 583 | 0.53 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.53 | Why? |
| Hospitals, High-Volume | 1 | 2017 | 688 | 0.53 | Why? |
| Prescription Drugs | 1 | 2017 | 243 | 0.51 | Why? |
| Antidepressive Agents | 1 | 2017 | 509 | 0.46 | Why? |
| Drug Prescriptions | 1 | 2019 | 1062 | 0.43 | Why? |
| Critical Pathways | 1 | 2021 | 1587 | 0.41 | Why? |
| Registries | 9 | 2020 | 12327 | 0.39 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.39 | Why? |
| Kidney Diseases | 2 | 2018 | 1434 | 0.38 | Why? |
| Heart Transplantation | 1 | 2019 | 1293 | 0.38 | Why? |
| Pain | 1 | 2017 | 1084 | 0.37 | Why? |
| Histocompatibility Testing | 1 | 2009 | 219 | 0.36 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.35 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.33 | Why? |
| Postoperative Complications | 4 | 2019 | 5861 | 0.33 | Why? |
| Opioid-Related Disorders | 1 | 2019 | 1185 | 0.33 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.32 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.32 | Why? |
| Transplant Recipients | 5 | 2021 | 4982 | 0.30 | Why? |
| Practice Patterns, Physicians' | 2 | 2018 | 4927 | 0.29 | Why? |
| Medicare | 2 | 2013 | 1048 | 0.29 | Why? |
| Tissue Donors | 3 | 2021 | 1679 | 0.28 | Why? |
| Healthcare Disparities | 3 | 2017 | 3893 | 0.25 | Why? |
| Patient Selection | 2 | 2018 | 4560 | 0.25 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.25 | Why? |
| Nephrectomy | 4 | 2019 | 406 | 0.25 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.24 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.24 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.23 | Why? |
| Liver Transplantation | 2 | 2019 | 2864 | 0.23 | Why? |
| Exercise Test | 1 | 2008 | 911 | 0.22 | Why? |
| Myocardial Ischemia | 1 | 2008 | 781 | 0.22 | Why? |
| Renal Dialysis | 3 | 2018 | 4358 | 0.21 | Why? |
| Proportional Hazards Models | 5 | 2017 | 6543 | 0.21 | Why? |
| Flow Cytometry | 1 | 2009 | 2393 | 0.21 | Why? |
| United States | 12 | 2021 | 46150 | 0.18 | Why? |
| Blood Group Incompatibility | 1 | 2018 | 44 | 0.18 | Why? |
| Pancreatic Diseases | 1 | 2020 | 191 | 0.18 | Why? |
| Intuition | 1 | 2017 | 9 | 0.18 | Why? |
| Coronary Angiography | 1 | 2008 | 2275 | 0.18 | Why? |
| Retrospective Studies | 14 | 2020 | 105322 | 0.18 | Why? |
| Transplantation Immunology | 1 | 2017 | 99 | 0.17 | Why? |
| Young Adult | 10 | 2020 | 93724 | 0.17 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.16 | Why? |
| Follow-Up Studies | 7 | 2019 | 17020 | 0.16 | Why? |
| Adult | 21 | 2021 | 244371 | 0.16 | Why? |
| Insurance, Health | 2 | 2020 | 634 | 0.16 | Why? |
| Cultural Competency | 1 | 2017 | 125 | 0.16 | Why? |
| Adolescent | 8 | 2020 | 86841 | 0.16 | Why? |
| North America | 1 | 2020 | 1400 | 0.15 | Why? |
| Middle East | 1 | 2020 | 1418 | 0.15 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.15 | Why? |
| Humans | 37 | 2021 | 930598 | 0.15 | Why? |
| Kaplan-Meier Estimate | 3 | 2017 | 4260 | 0.15 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.15 | Why? |
| Information Storage and Retrieval | 1 | 2020 | 644 | 0.14 | Why? |
| Latin America | 1 | 2020 | 1721 | 0.14 | Why? |
| Organ Transplantation | 2 | 2021 | 2616 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.14 | Why? |
| Allografts | 1 | 2017 | 761 | 0.13 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.13 | Why? |
| Asia | 1 | 2020 | 2399 | 0.13 | Why? |
| Thinness | 1 | 2013 | 99 | 0.13 | Why? |
| Risk Factors | 7 | 2019 | 71621 | 0.12 | Why? |
| Policy | 1 | 2021 | 1372 | 0.12 | Why? |
| Depression | 1 | 2017 | 14116 | 0.12 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.12 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.12 | Why? |
| Body Mass Index | 2 | 2017 | 4306 | 0.12 | Why? |
| Peripheral Vascular Diseases | 1 | 2013 | 133 | 0.12 | Why? |
| Male | 20 | 2021 | 367725 | 0.12 | Why? |
| Prognosis | 5 | 2019 | 32490 | 0.12 | Why? |
| Respiratory Insufficiency | 1 | 2013 | 7301 | 0.12 | Why? |
| Female | 20 | 2021 | 380317 | 0.12 | Why? |
| Waiting Lists | 2 | 2018 | 1388 | 0.11 | Why? |
| Counseling | 1 | 2018 | 747 | 0.11 | Why? |
| Travel | 1 | 2010 | 7220 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Ontario | 4 | 2018 | 1966 | 0.11 | Why? |
| Treatment Outcome | 8 | 2020 | 51732 | 0.11 | Why? |
| Databases, Factual | 2 | 2017 | 6248 | 0.10 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.10 | Why? |
| Internationality | 2 | 2020 | 3297 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.10 | Why? |
| Renal Artery Obstruction | 1 | 2009 | 27 | 0.10 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.10 | Why? |
| Cell Phone | 1 | 2017 | 750 | 0.10 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Respiration, Artificial | 1 | 2013 | 22116 | 0.09 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.09 | Why? |
| Cytotoxicity, Immunologic | 1 | 2009 | 287 | 0.08 | Why? |
| Kidney | 1 | 2021 | 3648 | 0.08 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.08 | Why? |
| Transplantation, Homologous | 1 | 2009 | 757 | 0.08 | Why? |
| Decision Making | 2 | 2018 | 3132 | 0.08 | Why? |
| Myocardial Revascularization | 1 | 2008 | 267 | 0.08 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Aged | 9 | 2020 | 215776 | 0.07 | Why? |
| Curriculum | 1 | 2018 | 3083 | 0.07 | Why? |
| Benchmarking | 1 | 2008 | 627 | 0.07 | Why? |
| Europe | 1 | 2020 | 12702 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.07 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Kidney Tubular Necrosis, Acute | 1 | 2021 | 56 | 0.06 | Why? |
| Social Class | 1 | 2010 | 1360 | 0.06 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Health Care Costs | 2 | 2018 | 1007 | 0.05 | Why? |
| Arrhythmias, Cardiac | 1 | 2013 | 2510 | 0.05 | Why? |
| Telemedicine | 2 | 2021 | 25032 | 0.05 | Why? |
| Lymphocyte Depletion | 1 | 2021 | 293 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.05 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.05 | Why? |
| Coronary Artery Disease | 1 | 2013 | 2570 | 0.05 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
| Residence Characteristics | 1 | 2008 | 1927 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.04 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.04 | Why? |
| Odds Ratio | 1 | 2008 | 5861 | 0.04 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.04 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3832 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Alberta | 1 | 2017 | 375 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Canada | 2 | 2018 | 6018 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| B-Lymphocytes | 1 | 2009 | 4418 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Morbidity | 1 | 2019 | 1426 | 0.03 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.03 | Why? |
| African Americans | 1 | 2008 | 3363 | 0.03 | Why? |
| Myocardial Infarction | 1 | 2008 | 3361 | 0.03 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.03 | Why? |
| T-Lymphocytes | 1 | 2009 | 6670 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.02 | Why? |
| Infant, Newborn | 1 | 2010 | 23105 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.02 | Why? |
| Aftercare | 1 | 2018 | 1637 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Infant | 1 | 2010 | 30274 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Child, Preschool | 1 | 2010 | 36283 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Health Services Accessibility | 1 | 2008 | 10697 | 0.02 | Why? |
| Child | 1 | 2010 | 70012 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
Lentine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(97)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_